1. Home
  2. LMRI vs PRCT Comparison

LMRI vs PRCT Comparison

Compare LMRI & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lumexa Imaging Holdings Inc. Common Stock

LMRI

Lumexa Imaging Holdings Inc. Common Stock

HOLD

Current Price

$10.70

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo PROCEPT BioRobotics Corporation

PRCT

PROCEPT BioRobotics Corporation

HOLD

Current Price

$18.67

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMRI
PRCT
Founded
2018
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
LMRI
PRCT
Price
$10.70
$18.67
Analyst Decision
Strong Buy
Buy
Analyst Count
5
11
Target Price
$20.75
$35.44
AVG Volume (30 Days)
268.4K
1.0M
Earning Date
05-12-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1.71
EPS
0.05
N/A
Revenue
N/A
$308,054,000.00
Revenue This Year
$6.35
$31.34
Revenue Next Year
$5.61
$24.52
P/E Ratio
$213.60
N/A
Revenue Growth
N/A
37.22
52 Week Low
$6.45
$16.67
52 Week High
$19.45
$39.86

Technical Indicators

Market Signals
Indicator
LMRI
PRCT
Relative Strength Index (RSI) 36.96 38.74
Support Level $10.09 $16.89
Resistance Level $12.69 $29.27
Average True Range (ATR) 0.55 1.08
MACD -0.13 -0.30
Stochastic Oscillator 0.57 2.03

Price Performance

Historical Comparison
LMRI
PRCT

About LMRI Lumexa Imaging Holdings Inc. Common Stock

Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Share on Social Networks: